Among other uPAR-related agents for in vivo tumor imaging is the Cy5.5-labeled monoclonal antibody, specifically detecting free and occupied uPAR in orthotopic mammary carcinomas in mice (Dullin et al., 2009). This evidence concerns the gene PLAUR and breast carcinoma.